Jonathan Hamilton Scott, MD

Offices

2 locations · County of Riverside · Riverside Faculty Medical Group Inc

Looking this up.

Hospitals listed: Riverside University Health System-Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Scott’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A180587 · Current

Licensed to practise in California · since 2022 · expires 2028-07-31 · University of California, Riverside School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

American Board of Internal Medicine - Internal Medicine

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 85.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Riverside University Health System-Medical CenterMoreno Valley, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Riverside University Health SystemPatients rate it 2 of 5 · 66% would definitely recommend it
Overall rating: 3 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.232, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025

See every measure and the patient survey for Riverside University Health System-Medical Center

Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Riverside University Health System-Medical Center

Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.232	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.157	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.38 (0.38 to 2.38) · 932 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.93 (0.56 to 1.3)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	191.06 (136.87 to 245.25) · 59 cases	No different	Jul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths	9.1 · 77 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	11.5 · 25 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	7.7 · 140 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	13.7 · 148 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	11.1 · 184 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	3.1 · 2,070 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.24 (0.02 to 0.46) · 4,158 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.35 (0.15 to 0.55) · 4,169 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	3.45 (1.15 to 5.76) · 582 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	1.6 (0 to 3.29) · 126 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	1.98 (0.38 to 3.58) · 580 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	9.8 (0.71 to 18.89) · 135 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	4.67 (0.57 to 8.78) · 125 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.67 (0.18 to 3.16) · 159 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.38 (0 to 1.09) · 3,702 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	4.1 · 48 cases	None	Apr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.517	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	1.484	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.896	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.404	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	15 · 46 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	22.1 · 303 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	7.1 · 162 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	1 · 164 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	19 · 290 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	6 (3.8 to 9.1) · 36 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	11.9 (8.1 to 16.7) · 36 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.8 · 60 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.2 · 151 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.6 (9.3 to 17) · 127 cases	No different	Jan 2022 – Dec 2024

What patients said (416 patients answered, 10% of those asked)

Sort by

Patient survey stars by topic at Riverside University Health System-Medical Center

Cleanliness	2
Nurse communication	2
Doctor communication	2
Communication about medicines	2
Discharge information	3
Overall hospital rating	3
Quietness	2
Recommend hospital	3

Sort by

Share of patients giving the best answer at Riverside University Health System-Medical Center

Room was "always" clean	63%
Nurses "always" communicated well	73%
Doctors "always" communicated well	74%
Staff "always" explained	54%
Yes, staff "did" give patients this information	85%
Yes, staff "did" give patients information about help after discharge	86%
Doctors "always" explained things so they could understand	69%
Doctors "always" listened carefully	72%
Doctors "always" treated them with courtesy and respect	82%
Patients who gave a rating of "9" or "10" (high)	65%
Staff "always" explained new medications	72%
Nurses "always" explained things so they could understand	69%
Nurses "always" listened carefully	69%
Nurses "always" treated them with courtesy and respect	81%
"Always" quiet at night	46%
"YES", patients would definitely recommend the hospital	66%
Staff "always" explained possible side effects	37%
Yes, staff "did" give patients information about possible symptoms	84%

Original Medicare doctor bills

$5,745

Medicare paid this office $5,745 for 38 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	16	$1,696	$63
Hospital discharge day management, more than 30 minutes	14	$1,277	$91

Who their Medicare patients are

38 Original Medicare patients in 2024. Average age 66 · Under 65 34% · Women 66% · Health risk score 3.27. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.

Conditions among them: High blood pressure 75% · Diabetes 55% · Depression 47% · Heart failure 45% · Chronic kidney disease 45% · Coronary heart disease 42% · COPD 42% · Dementia 37% · Stroke 29%.

The office billed $17,859, Medicare allowed $7,241 and paid $5,745; for 72 services of 11 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	38	72	66	3.27	$17,859	$5,745
2023	29	57	67	2.70	$11,913	$5,012
2022	22	40	76	2.52	$9,365	$3,431

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 1 service

Sort by

Original Medicare services billed in 2023

Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	12	$2,508	$96

2022: 1 service

Sort by

Original Medicare services billed in 2022

Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	11	$1,578	$83

Medicaid work

$23,125 in 2024

Medicaid paid $23,125 for 11,781 billed services this clinician did in 2024, up to 177 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2024

Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use	40	$7,980
Clinic visit/encounter, all-inclusive	1,608	$6,648
Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use	82	$5,684
Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use	48	$1,029
Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter	13	$489
Short return visit (20+ min)	1,761	$387
Short return visit	254	$377
Return visit (30+ min)	1,226	$223
Screening for depression is documented as negative, a follow-up plan is not required	1,640	$85
Hemoglobin A1C level	280	$76
Screening performed and positive and provision of recommendations	78	$58
Screening performed and negative	114	$58

Sort by

Medicaid work by year

2024	11,781	22	177	$23,125
2023	8,450	22	150	$12,933
2022	2,239	12	121	$2,901

See the largest Medicaid services in earlier years

2023

Sort by

Largest Medicaid services in 2023

Clinic visit/encounter, all-inclusive	1,305	$6,268
Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use	15	$2,581
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES	35	$1,904
Short return visit (20+ min)	2,047	$1,158
Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter	12	$519
Return visit (30+ min)	335	$209
Short return visit	100	$163
Screening performed and negative	41	$58
Hemoglobin A1C level	143	$39
Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use	31	$21
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)	106	$13
Administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument	18	$0

2022

Sort by

Largest Medicaid services in 2022

Clinic visit/encounter, all-inclusive	439	$2,047
Short return visit (20+ min)	602	$635
Short return visit	77	$144
Return visit (30+ min)	68	$75
Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD)	200	$0
Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD)	13	$0
Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM)	32	$0
Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM)	156	$0
Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM)	109	$0
Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM)	14	$0
Screening for depression is documented as negative, a follow-up plan is not required	317	$0
Alcohol and/or drug screening	212	$0

Drugs they prescribed that Part D paid

$501,166

Pharmacies billed $501,166 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 1% of their Part D prescriptions (13 of 2,249) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.

1,716 generic and 512 brand-name prescriptions · $501,166 in drug cost · 21 antibiotic prescriptions to 17 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Ozempic	123	$128,053	$1,041
Jardiance	48	$52,453	$1,093
Eliquis	26	$33,082	$1,272
Entresto	12	$16,790	$1,399
Januvia	12	$16,091	$1,341

See all 55 drugs

Sort by

Every Part D drug this clinician prescribed

Ozempic	123	$128,053	$1,041
Jardiance	48	$52,453	$1,093
Eliquis	26	$33,082	$1,272
Entresto	12	$16,790	$1,399
Januvia	12	$16,091	$1,341
Trulicity	13	$15,852	$1,219
Farxiga	14	$15,684	$1,120
Trelegy Ellipta	22	$13,743	$625
Basaglar Kwikpen U-100	14	$4,997	$357
Lidocaine	44	$2,680	$61
Lantus Solostar	23	$2,442	$106
Atorvastatin	188	$2,207	$12
Diclofenac	42	$1,480	$35
Albuterol Sulfate Hfa	35	$1,424	$41
Nifedipine Er	45	$1,262	$28
Bumetanide	11	$1,102	$100
Tamsulosin	31	$929	$30
Famotidine	57	$905	$16
Gabapentin	68	$869	$13
Baclofen	25	$718	$29
Metformin	95	$659	$7
Celecoxib	15	$620	$41
Lactulose	18	$582	$32
Losartan	64	$543	$8
Pregabalin	15	$537	$36
Ipratropium	14	$524	$37
Levothyroxine	39	$496	$13
Pantoprazole	34	$391	$12
Furosemide	53	$374	$7
Finasteride	16	$358	$22
Amlodipine Besylate	81	$354	$4
Benazepril	45	$351	$8
Duloxetine	16	$324	$20
Potassium Chloride	18	$285	$16
Carvedilol	36	$261	$7
Omeprazole	28	$247	$9
Hydralazine	17	$243	$14
Lisinopril	36	$238	$7
Metoprolol	19	$235	$12
Sertraline	18	$187	$10
Ibuprofen	26	$169	$6
Methocarbamol	12	$159	$13
Alendronate	12	$158	$13
Mirtazapine	11	$143	$13
Ropinirole	15	$112	$7
Spironolactone	18	$109	$6
Hydrochlorothiazide	23	$104	$5
Fluticasone Propionate	17	$99	$6
Hydrocodone-Acetaminophen	11	$93	$8
Ondansetron	12	$90	$7
Cyclobenzaprine	13	$87	$7
Meloxicam	21	$77	$4
Clopidogrel	14	$69	$5
Trazodone	12	$49	$4
Metoprolol	14	$32	$2

Year by year

Sort by

Part D prescribing by year

2024	2,249	364	1% (13)	23%	$501,166
2023	1,425	283	None	25%	$314,558
2022	304	100	None	None	$40,349

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 30 drugs

Sort by

Part D drugs prescribed in 2023

Ozempic	59	$84,571	$1,433
Jardiance	33	$52,520	$1,592
Trulicity	21	$31,566	$1,503
Farxiga	13	$18,957	$1,458
Eliquis	13	$16,742	$1,288
Lantus Solostar	17	$7,036	$414
Diclofenac	57	$4,095	$72
Atorvastatin	122	$3,296	$27
Albuterol Sulfate Hfa	34	$1,695	$50
Famotidine	44	$1,399	$32
Nifedipine Er	23	$1,391	$60
Lidocaine	20	$1,347	$67
Ventolin Hfa	18	$1,211	$67
Gabapentin	37	$1,151	$31
Losartan	50	$919	$18
Metformin	52	$819	$16
Hydralazine	18	$718	$40
Carvedilol	29	$656	$23
Amlodipine Besylate	41	$599	$15
Metoprolol	17	$587	$35
Lisinopril	28	$544	$19
Levothyroxine	25	$532	$21
Benazepril	28	$502	$18
Tamsulosin	17	$470	$28
Alendronate	18	$443	$25
Pantoprazole	17	$380	$22
Furosemide	42	$318	$8
Omeprazole	14	$280	$20
Fluticasone Propionate	13	$159	$12
Hydrochlorothiazide	13	$77	$6

2022: 3 drugs

Sort by

Part D drugs prescribed in 2022

Atorvastatin	20	$639	$32
Diclofenac	19	$463	$24
Furosemide	11	$141	$13

Money from drug and device companies

$29 in 2024

A payment is not proof that care is biased.

Sort by

Payments by company

Amgen	Repatha	$29	1 payment Meals for Repatha · 2024-06-19 · $29

See the published payment

Sort by

Every published payment

Amgen	Meals · 2024-06-19	Repatha	$29

Professional record

NPI: 1922561265
Licence: CA A180587California A180587: Current · expires 2028-07-31
Trained: Loma Linda University School of Medicine, 2022 · 4 years ago
Group: County of Riverside · Riverside Faculty Medical Group Inc
Gender: Male

More record details

Sole proprietor: Yes
Taxonomy: Internal medicine (207R00000X)
Mailing address: 300 Pasteur Dr, Palo Alto, CA, 94304
NPI first listed: 2019-04-12
NPI last updated: 2026-06-17
NPI record certified: 2026-06-17

This is when the NPI record was last certified, not a medical board exam.